Aim: This study was aimed to determine which scale (centesimal or 50 millesimal) is more effective in the management of acute bronchitis in the age group of 1 to 15 yrs and also to assess the efficacy of different potencies in two scales.
Methodology: The selection of 60 cases of 1 to 15 yrs of age group suffering from acute bronchitis from the outpatient / inpatient and rural centers of Sarada Krishna HMC. The patients were included into 2 groups, each with 30 patients. For group-I, indicated medicines were administered in centesimal (30, 200, 1M……) potencies. For group-II, indicated medicines were administered in 50 millesimal (0/3, 0/6, 0/9, 0/12 ……) potencies. The cases were confirmed based on clinical symptoms and followed up for 3 weeks. Observation score before treatment were compared with the scores of after treatment and to find out the effectiveness of both centesimal scale potency and fifty millesimal scale potencies, paired t test was done separately and for comparison between centesimal potency and fifty millesimal scale potencies unpaired ‘t’ test was applied.
Result: Among 30 cases in centesimal scale potencies, 13 (43%) patients with marked improvement; 16 (54%) with moderate improvement and 1 (3%) had mild improvement. In the 30 cases with 50 millesimal scale potencies, 2 (6.67%) patients had marked improvement; 15 (50%) with moderate improvement and 13 (43%) with mild improvement. In analysis, the calculated t value (9.36) is greater than the tabled t value (2.048) at 5% level of significance with n-2 degrees of freedom, which suggests that the test is significant statistically. This shows that centesimal scale potencies was found to be more effective than 50 millesimal scale potencies in the management of acute bronchitis in this age group of 1 to 15 yrs.